SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-085422
Filing Date
2024-08-02
Accepted
2024-08-02 16:53:03
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm2420634-1_s3.htm S-3 592579
2 EXHIBIT 1.2 tm2420634d2_ex1-2.htm EX-1.2 235821
3 EXHIBIT 5.1 tm2420634d2_ex5-1.htm EX-5.1 46647
4 EXHIBIT 23.1 tm2420634d2_ex23-1.htm EX-23.1 2963
5 EX-FILING FEES tm2420634d2_ex-filingfees.htm EX-FILING FEES 44156
6 GRAPHIC tm2420634d2_ex5-1img001.jpg GRAPHIC 6150
7 GRAPHIC lg_rigelreg-4c.jpg GRAPHIC 36467
  Complete submission text file 0001104659-24-085422.txt   979320
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281230 | Film No.: 241171832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)